C23H33N7O5S.C6H6O3S
Neat
519.62 158.17
GISADENAFIL BESYLATE; 334827-98-4; Gisadenafil besylate [USAN]; Gisadenafil besylate (USAN); UNII-T4S08274OY; T4S08274OY; UK-369, 003-26; DTXSID20187125; UK-369003-26; 7H-Pyrazolo(4, 3-d)pyrimidin-7-one, 5-(2-ethoxy-5-((4-ethyl-1-piperazinyl)sulfonyl)-3-pyridinyl)-3-ethyl-2, 6-dihydro-2-(2-methoxyethyl)-, benzenesulfonate (1:1); 5-(2-ethoxy-5-((4-ethylpiperazin-1-yl)sulfonyl)pyridin-3-yl)-3-ethyl-2-(2-methoxyethyl)-2, 6-dihydro-7H-pyrazolo(4, 3-d)pyrimidin-7-one benzenesulfonate; 5-(2-ETHOXY-5-((4-ETHYLPIPERAZIN-1-YL)SULPHONYL)PYRIDIN-3-YL)-3-ETHYL-2-(2-METHOXYETHYL)-2, 6-DIHYDRO-7H-PYRAZOLO(4, 3-D)PYRIMIDIN-7-ONE BENZENESULPHONATE; 7H-PYRAZOLO(4, 3-D)PYRIMIDIN-7-ONE, 5-(2-ETHOXY-5-((4-ETHYL-1-PIPERAZINYL)SULPHONYL)-3-PYRIDINYL)-3-ETHYL-2, 6-DIHYDRO-2-(2-METHOXYETHYL)-, BENZENESULPHONATE (1:1); 5-{2-Ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]pyridin-3-yl}-3-ethyl-2-(2-methoxyethyl)-2, 6-dihydro-7H-pyrazolo[4, 3-d]pyrimidin-7-one benzenesulfonate; RefChem:143246; DTXCID30109616; Gisadenafil (besylate); Gisadenafil besylate salt; UK-369003-26 BESYLATE; 5-[2-Ethoxy-5-[(4-ethyl-1-piperazinyl)sulfonyl]-3-pyridinyl]-3-ethyl-2, 6-dihydro-2-(2-methoxyethyl)-7H-pyrazolo[4 and 3-d]pyrimidin-7-onebenzenesulfonate
benzenesulfonic acid;5-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonyl-3-pyridinyl]-3-ethyl-2-(2-methoxyethyl)-6H-pyrazolo[4 and 3-d]pyrimidin-7-one
InChI=1S/C23H33N7O5S.C6H6O3S/c1-5-18-19-20(27-30(18)12-13-34-4)22(31)26-21(25-19)17-14-16(15-24-23(17)35-7-3)36(32,33)29-10-8-28(6-2)9-11-29;7-10(8,9)6-4-2-1-3-5-6/h14-15H,5-13H2,1-4H3,(H,25,26,31);1-5H,(H,7,8,9)